Christophe Furman researcher
Furman, Christophe
VIAF ID: 318145541844696600039 (Personal)
Permalink: http://viaf.org/viaf/318145541844696600039
Preferred Forms
- 100 0 _ ‡a Christophe Furman ‡c researcher
- 100 1 _ ‡a Furman, Christophe
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
6-Sulfonylbenzothiazolones as potential scaffolds for the design of 5-HT6 ligands | |
Antagonists of the adenosine A2A receptor based on a 2-arylbenzoxazole scaffold: Investigation of the C5- and C7-positions to enhance affinity. | |
Antagonists of the P2X7 receptor: mechanism of enantioselective recognition using highly sulfated and sulfobutylether cyclodextrins by capillary electrokinetic chromatography. | |
Apolipoprotein E knockout mice over-expressing human tissue inhibitor of metalloproteinase 1 are protected against aneurysm formation but not against atherosclerotic plaque development | |
Daily melatonin supplementation in mice increases atherosclerosis in proximal aorta | |
Development and validation of a reversed-phase HPLC method for the quantification of paclitaxel in different PLGA nanocarriers | |
Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells. | |
Di-tert-butylhydroxylated flavonoids protect endothelial cells against oxidized LDL-induced cytotoxicity. | |
Differential toxicities of air (mO-LDL) or copper-oxidized LDLs (Cu-LDL) toward endothelial cells. | |
Enantioseparation of pyroglutamide derivatives on polysaccharide based chiral stationary phases by high-performance liquid chromatography and supercritical fluid chromatography: a comparative study. | |
Enhanced VDUP-1 gene expression by PPARgamma agonist induces apoptosis in human macrophage | |
Evaluation and comparison of three different separation techniques for analysis of retroamide enantiomers and their biological evaluation against h-P2X7 receptor | |
Extracellular human thioredoxin-1 inhibits lipopolysaccharide-induced interleukin-1beta expression in human monocyte-derived macrophages. | |
Increased susceptibility of low-density lipoprotein to ex vivo oxidation in mice transgenic for human apolipoprotein B treated with 1 melatonin-related compound is not associated with atherosclerosis progression | |
Oxidized phospholipids activate PPARα in a phospholipase A2-dependent manner | |
Ozonized low density lipoprotein (ozLDL) inhibits NF-kappaB and IRAK-1-associated signaling. | |
Part 2: discovery of new agonists endowed with protective effect against experimental colitis. | |
Perilipin, a potential substitute for adipophilin in triglyceride storage in human macrophages | |
Potent farnesyltransferase inhibitors with 1,4-diazepane scaffolds as novel destabilizing microtubule agents in hormone-resistant prostate cancer. | |
Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease | |
REDD2 gene is upregulated by modified LDL or hypoxia and mediates human macrophage cell death. | |
Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability. | |
Scaffold hopping strategy toward original pyrazolines as selective CB2 receptor ligands | |
Synthesis and pharmacological evaluation of benzannulated derivatives as potent and selective sigma-1 protein ligands | |
Systemic tissue inhibitor of metalloproteinase-1 gene delivery reduces neointimal hyperplasia in balloon-injured rat carotid artery | |
Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators. | |
Thioredoxin-1 and its natural inhibitor, vitamin D3 up-regulated protein 1, are differentially regulated by PPARalpha in human macrophages | |
Virtual screening of CB(2) receptor agonists from bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR features. |